亚洲精品国产精华液,污污的网站国产乱伦无码,久久激情五月天综合av,色综合天天综合网国产成人网

歡迎來到上海起發(fā)生物科技有限公司網(wǎng)站!
咨詢電話:13308436663

當前位置:首頁  >  技術文章  >  C1 Esterase Inhibitor (C1-INH)說明書

C1 Esterase Inhibitor (C1-INH)說明書

更新時間:2023-10-24      點擊次數(shù):1743

C1 Esterase Inhibitor (C1-INH)說明書

11.png

產品描述
The protease inhibitor C1-INH prevents the spontaneous activation of complement and limits consumption of C2 and C4 by rapidly inactivating C1r, C1s and MASP2. It is the only plasma serine protease inhibitor (Serpin) capable of interacting with and inhibiting activated C1. C1-INH interacts with the catalytic sites of both C1r and C1s. The interaction with activated C1r and C1s is covalent resulting in complexes which are stable to SDS. The binding of C1-INH to activated C1 releases both C1r and C1s from the complex leaving C1q bound to the immune complex. The released complexes contain four molecules: C1-INH-C1r-C1s-C1-INH. The reaction of C1 esterase inhibitor with activated C1 is very fast with the estimated half-life of C1r and C1s being approximately 15 seconds in serum. In fact, at serum concentrations of C1- INH little or no additional C4 or C2 activation occurs 3 min after immune complexes are added because all the C1r and C1s molecules have been inactivated and removed from the C1q which remains bound to the immune complex (Ross, G.D. (1986); Morley, B.J. and Walport, M.J. (2000); Rother, K., et al. (1998); Ziccardi, R.J. (1982a and 1982b); Morgan, B.P. (1990)). C1-INH is thought to bind to and stabilize unactivated C1r and C1s in the C1 complex thus retarding their spontaneous activation (Ziccardi, RJ. (1982b)).
C1-INH plays an important role in suppression of inflammation and control of vascular permeability. Through its ability to inhibit complement proteases (C1r, C1s and MASP2) and to express a variety of other biological functions (Davis III, A.E. et al. (2008)) C1-INH is able to regulate inflammatory reactions in sepsis, endotoxic shock, ischemia-reperfusion injury, transplantation, and other bacterial and parasitic infections. Through its ability to control contact system activation it inhibits bradykinin generation and this controls vascular permeability. This function is most apparent in patients with a physical or functional deficiency of C1-INH. Hereditary angioedema (HAE) patients suffer from enhanced blood vessel permeability and tissue swelling or edema. Most patients are heterozygous and have 15% to 30 % of the normal level of functional C1- INH in blood.
產品性質
Sizes Available: 1000 µg/vial
Concentration: 1.0 mg/mL (see Certificate of Analysis for actual concentration)
Form: Frozen liquid
Activity: >90 % active protein
Purity: >95 % by SDS PAGE
Buffer: 10 mM sodium phosphate, 145 mM NaCl, pH 7.3
Extinction Coeff. A280 nm = 0.45 at 1.0 mg/mL
Molecular Weight: 110,000 Da (single chain)
Preservative: None, 0.22 µm filtered.
Source: Normal human serum (shown by certified tests to be negative for HBsAg, HTLV-I/II, STS, and for antibodies to HCV, HIV-1 and HIV-II).
Precautions: Use normal precautions for handling human blood products.
注意事項
This protein is purified from human serum and therefore precautions appropriate for handling any blood-derived product must be used even though the source was shown by certified tests to be negative for HBsAg, HTLV-I/II, STS, and for antibodies to HCV, HIV-1 and HIV-II.
運輸及保存方法
-70℃ or below.Avoid freeze/thaw.
產品用途
C1-INH has an apparent molecular weight of 110,000 Da. It is a single chain protein that is highly glycosylated with approximately 30 to 40% carbohydrate. It is synthesized as a 500 amino acid protein. Removal if the signal peptide results in a plasma protein that contains 478 amino acids. The calculated molecular weight based on amino acids is 53,000 g/mole, however due to extensive glycosylation its mass is closer to 75,000. It runs abnormally on many gel systems giving apparent molecular weights from 90,000 to 115,000 MW. The glycosylation sites include six N-linked and six or seven O-linked sites. C1-INH is an extremely acidic protein with a pI of less than 3.0.
The genetic disorder HAE is caused by a partial deficiency of C1-INH. Replacement therapy with a C1-INH concentrate produced by a number of drug companies has been approved for use in both Europe and the USA. These concentrates are administered intravenously and increase blood levels of C1-INH 2- to 3-fold. A typical treatment includes administration of 1000 Units (approximately 200 mg) and the blood level may remain elevated for 2-4 days.


貨號品名規(guī)格品牌
78AH10007-1000ugC1 Esterase Inhibitor (C1-INH)1000ugBIOHUB



掃碼關注

郵箱:xs1@78bio.com

地址:上海市浦東新區(qū)川沙新鎮(zhèn)6619號

版權所有©2025 上海起發(fā)生物科技有限公司 All Rights Reserved    備案號:滬ICP備2022022359號-2    sitemap.xml    管理登陸    技術支持:化工儀器網(wǎng)
黑丝美女啊啊啊被操出水| 九九视频免费在线观看精品| 亚洲国产欧洲综合997| 国产乱人乱精一区二视频| 欧美日韩成人精品久久二区| 精品久久久久久性色av| 丰满人妻熟妇乱又伦精品| 亚洲欧洲精品成人久久曰影片| 亚洲娇小与黑人巨大交| 欧美一欧美一区二三区性| 欧美日韩人妻精品区二区| 男人午夜爰影院| 亚洲精品美女久久久久99| 永久免费a∨片在线观看| 亚洲欧美熟妇综合久久久久久| 不卡无在线一区欧美二区| a毛片免费全部播放视频| 手机亚洲自拍偷拍另类激情| 777久久人妻少妇嫩草av| 三级精品久久久久电影网| 麻豆av天堂一区二区香蕉| 国产精品久久一区二区三| 欧美高清精品video| 久久精品a一国产成人免费网站| 久久人妻无码毛片a片麻豆| 日本一区二区无卡高清视频| 黑人巨大无码中文字幕无码| 一级片免费无码手机观看| 日本在线一区二区三区电影| 久久亚洲精品ab无码播放| 国产精品一区二区亚洲推荐| 国产调教性奴在线观看w| 日韩av一区二区 三区| 男生插女生下面在线免费| 亚洲色多多视频一区二区| 国产自拍在线观看| 国产午夜无码视频在线观看| 日韩欧美在线观看网址导航| 国产av一区最新精品麻豆| 狂操老熟女骚逼高潮视频| 天堂在线www|